Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:961-968

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, M. J.
Right arrow Articles by Schwaiger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, M. J.
Right arrow Articles by Schwaiger, M.

(Circulation. 1998;98:961-968.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Cardiac Sympathetic Dysinnervation in Diabetes

Implications for Enhanced Cardiovascular Risk

Martin J. Stevens, MD; David M. Raffel, PhD; Kevin C. Allman, MD; Firat Dayanikli, MD; Edward Ficaro, PhD; Tracy Sandford, RN; Donald M. Wieland, PhD; Michael A. Pfeifer, MD; ; Markus Schwaiger, MD

From the Divisions of Endocrinology and Metabolism (M.J.S., T.S.) and Nuclear Medicine (D.M.R., K.C.A., F.D., E.F., D.M.W., M.S.), Department of Internal Medicine, University of Michigan, Ann Arbor, Mich, and Diabetes Research and Treatment Center (M.A.P.), Southern Illinois University School of Medicine, Springfield, Ill.

Background—Regional cardiac sympathetic hyperactivity predisposes to malignant arrhythmias in nondiabetic cardiac disease. Conversely, however, cardiac sympathetic denervation predicts increased morbidity and mortality in severe diabetic autonomic neuropathy (DAN). To unite these divergent observations, we propose that in diabetes regional cardiac denervation may elsewhere induce regional sympathetic hyperactivity, which may in turn act as a focus for chemical and electrical instability. Therefore, the aim of this study was to explore regional changes in sympathetic neuronal density and tone in diabetic patients with and without DAN.

Methods and Results—PET using the sympathetic neurotransmitter analogue 11C-labeled hydroxyephedrine ([11C]-HED) was used to characterize left ventricular sympathetic innervation in diabetic patients by assessing regional disturbances in myocardial tracer retention and washout. The subject groups comprised 10 diabetic subjects without DAN, 10 diabetic subjects with mild DAN, 9 diabetic subjects with severe DAN, and 10 healthy subjects. Abnormalities of cardiac [11C]-HED retention were detected in 40% of DAN-free diabetic subjects. In subjects with mild neuropathy, tracer defects were observed only in the distal inferior wall of the left ventricle, whereas with more severe neuropathy, defects extended to involve the distal and proximal anterolateral and inferior walls. Absolute [11C]-HED retention was found to be increased by 33% (P<0.01) in the proximal segments of the severe DAN subjects compared with the same regions in the DAN-free subjects (30%; P<0.01 greater than the proximal segments of the mild DAN subjects). Despite the increased tracer retention, no appreciable washout of tracer was observed in the proximal segments, consistent with normal regional tone but increased sympathetic innervation. Distally, [11C]-HED retention was decreased in severe DAN by 33% (P<0.01) compared with the DAN-free diabetic subjects (21%; P<0.05 lower than the distal segments of the mild DAN subjects).

Conclusions—Diabetes may result in left ventricular sympathetic dysinnervation with proximal hyperinnervation complicating distal denervation. This combination could result in potentially life-threatening myocardial electrical instability and explain the enhanced cardioprotection from ß-blockade in these subjects.


Key Words: diabetes mellitus • nervous system, autonomic • imaging • ventricles




This article has been cited by other articles:


Home page
CirculationHome page
A. I. Vinik and D. Ziegler
Diabetic Cardiovascular Autonomic Neuropathy
Circulation, January 23, 2007; 115(3): 387 - 397.
[Full Text] [PDF]


Home page
JNMHome page
D. M. Raffel, R. A. Koeppe, R. Little, C.-N. Wang, S. Liu, L. Junck, M. Heumann, and S. Gilman
PET Measurement of Cardiac and Nigrostriatal Denervation in Parkinsonian Syndromes
J. Nucl. Med., November 1, 2006; 47(11): 1769 - 1777.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger
Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation
J. Nucl. Med., September 1, 2006; 47(9): 1413 - 1419.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. M. Raffel, W. Chen, P. S. Sherman, D. L. Gildersleeve, and Y.-W. Jung
Dependence of Cardiac 11C-meta-Hydroxyephedrine Retention on Norepinephrine Transporter Density
J. Nucl. Med., September 1, 2006; 47(9): 1490 - 1496.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M.-R. Movahed, M. Hashemzadeh, and M. M. Jamal
Increased Prevalence of Third-Degree Atrioventricular Block in Patients With Type II Diabetes Mellitus
Chest, October 1, 2005; 128(4): 2611 - 2614.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G A Suarez, V M Clark, J E Norell, T E Kottke, M J Callahan, P C O'Brien, P A Low, and P J Dyck
Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 240 - 245.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Pop-Busui, I. Kirkwood, H. Schmid, V. Marinescu, J. Schroeder, D. Larkin, E. Yamada, D. M. Raffel, and M. J. Stevens
Sympathetic dysfunction in type 1 diabetes: Association with impaired myocardial blood flow reserve and diastolic dysfunction
J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2368 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Arch Intern Med, September 13, 2004; 164(16): 1737 - 1748.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z. Y. Fang, J. B. Prins, and T. H. Marwick
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Endocr. Rev., August 1, 2004; 25(4): 543 - 567.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
L. A. Scott and P. L. Kench
Cardiac Autonomic Neuropathy in the Diabetic Patient: Does 123I-MIBG Imaging Have a Role to Play in Early Diagnosis?
J. Nucl. Med. Technol., June 1, 2004; 32(2): 66 - 71.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Laine, J Sundell, P Nuutila, O T Raitakari, M Luotolahti, T Ronnemaa, T Elomaa, P Koskinen, and J Knuuti
Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes
Heart, March 1, 2004; 90(3): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. F. Beek, J. A. P. van der Sloot, M. Huikeshoven, H. J. Verberne, B. L. F. van Eck-Smit, J. van der Meulen, J. G. P. Tijssen, M. J. C. van Gemert, and R. Tukkie
Cardiac denervation after clinical transmyocardial laser revascularization: Short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 517 - 524.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young
Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration
Diabetes Care, February 1, 2004; 27(2): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. T. Hurst and R. W. Lee
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Ann Intern Med, November 18, 2003; 139(10): 824 - 834.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman
Diabetic Autonomic Neuropathy
Diabetes Care, May 1, 2003; 26(5): 1553 - 1579.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Foo, N Sekhri, A Deaner, C Knight, A Suliman, K Ranjadayalan, and A D Timmis
Effect of diabetes on serum potassium concentrations in acute coronary syndromes
Heart, January 1, 2003; 89(1): 31 - 35.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. R. Shotton, S. Clarke, and J. Lincoln
The Effectiveness of Treatments of Diabetic Autonomic Neuropathy Is Not the Same in Autonomic Nerves Supplying Different Organs
Diabetes, January 1, 2003; 52(1): 157 - 164.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Taskiran, T. Fritz-Hansen, V. Rasmussen, H. B.W. Larsson, and J. Hilsted
Decreased Myocardial Perfusion Reserve in Diabetic Autonomic Neuropathy
Diabetes, November 1, 2002; 51(11): 3306 - 3310.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Huikeshoven, J. F. Beek, J. A.P. van der Sloot, R. Tukkie, J. van der Meulen, and M. J.C. van Gemert
35 years of experimental research in transmyocardial revascularization: what have we learned?
Ann. Thorac. Surg., September 1, 2002; 74(3): 956 - 970.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Nitenberg, S. Ledoux, P. Valensi, R. Sachs, and I. Antony
Coronary Microvascular Adaptation to Myocardial Metabolic Demand Can Be Restored by Inhibition of Iron-Catalyzed Formation of Oxygen Free Radicals in Type 2 Diabetic Patients
Diabetes, March 1, 2002; 51(3): 813 - 818.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. R. Russell III, D. Chyun, S. Song, R. S. Sherwin, W. V. Tamborlane, F. A. Lee, M. A. Pfeifer, F. Rife, F. J. T. Wackers, and L. H. Young
Cardiac responses to insulin-induced hypoglycemia in nondiabetic and intensively treated type 1 diabetic patients
Am J Physiol Endocrinol Metab, November 1, 2001; 281(5): E1029 - E1036.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. M. Consolim-Colombo, J. A. B. Filho, H. F. Lopes, C. R. R. Sobrinho, M. E. Otto, G. M. G. Riccio, C. Mady, and E. M. Krieger
Decreased Cardiopulmonary Baroreflex Sensitivity in Chagas' Heart Disease
Hypertension, December 1, 2000; 36(6): 1035 - 1039.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. Matsunari, U. Schricke, F. M. Bengel, H.-U. Haase, P. Barthel, G. Schmidt, S. G. Nekolla, A. Schoemig, and M. Schwaiger
Extent of Cardiac Sympathetic Neuronal Damage Is Determined by the Area of Ischemia in Patients With Acute Coronary Syndromes
Circulation, June 6, 2000; 101(22): 2579 - 2585.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. V. Jayachandran, H. J. Sih, W. Winkle, D. P. Zipes, G. D. Hutchins, and J. E. Olgin
Atrial Fibrillation Produced by Prolonged Rapid Atrial Pacing Is Associated With Heterogeneous Changes in Atrial Sympathetic Innervation
Circulation, March 14, 2000; 101(10): 1185 - 1191.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. F. Di Carli, D. Bianco-Batlles, M. E. Landa, A. Kazmers, H. Groehn, O. Muzik, and G. Grunberger
Effects of Autonomic Neuropathy on Coronary Blood Flow in Patients With Diabetes Mellitus
Circulation, August 24, 1999; 100(8): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Al-Sheikh, K. B. Allen, S. P. Straka, D. A. Heimansohn, R. L. Fain, G. D. Hutchins, S. G. Sawada, D. P. Zipes, and E. D. Engelstein
Cardiac Sympathetic Denervation After Transmyocardial Laser Revascularization
Circulation, July 13, 1999; 100(2): 135 - 140.
[Abstract] [Full Text] [PDF]